News for ABC Stock

Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase AmerisourceBergen Reports Fiscal 2023 Third Quarter Results AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds AmerisourceBergen Reports Fiscal 2023 Second Quarter Results AmerisourceBergen Launches Cell and Gene Therapy Innovation Hub TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release X-energy Announces Appointments of Christopher Ginther and Kathleen Hyle to Board of Directors AmerisourceBergen Reports Fiscal 2023 First Quarter Results AmerisourceBergen Announces Intent to Change Name to Cencora AmerisourceBergen Kicks Off Strategic Relationship with Civica AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release AmerisourceBergen Completes Acquisition of PharmaLex AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex AmerisourceBergen Reports Fiscal 2022 Third Quarter Results AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release Seefried Properties Break Ground on New Distribution Facility in Mount Prospect, IL AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook AmerisourceBergen Provides Update on Capital Deployment Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation AmerisourceBergen Reports Fiscal 2022 Second Quarter Results Distributors Agree to Opioid Settlement With Washington State AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day Distributors Approve Opioid Settlement Agreement AmerisourceBergen to Participate in Baird Sustainability Conference AmerisourceBergen Reports Fiscal 2022 First Quarter Results AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release Distributors Announce Extension of Opioid Settlement Sign-On Period, Participation of New Mexico AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release Distributors Announce Settlement With Cherokee Nation Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase AmerisourceBergen to Participate in Upcoming Investor Conferences AmerisourceBergen Reports Fiscal 2021 Third Quarter Results Distributors Announce Proposed Opioid Settlement Agreement Distributors Reach Opioid Settlement Agreement With New York State AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release AmerisourceBergen to Participate in Upcoming Investor Conferences AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses AmerisourceBergen Reports Fiscal 2021 Second Quarter Results AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031 AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031 AmerisourceBergen Reports Fiscal 2021 First Quarter Results AmerisourceBergen Announces Quarterly Dividend AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2021 Earnings Release and Participation in Upcoming Investor Conferences AmerisourceBergen Reports Fiscal 2020 Fourth Quarter and Year End Results AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2020 Earnings Release